AdaptHealth Corp.

AdaptHealth Corp.

AHCOยทNASDAQ

$9.72

+0.73%
HealthcareMedical - Devices

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$1.32B
EPS-0.5200
P/E Ratio-18.69
Earnings Date08/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

Medium confidence

Valuation multiple is compressed (P/E -18.7).

Valuation inputs: P/E -18.7, earnings yield N/A, momentum +0.7%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE -4.7%, ROIC +5.1%).

Profitability stack: net margin -2.2%, ROE -4.7%, ROIC +5.1%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +64.6%, momentum +0.7%, net margin -2.2%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

ahco

AdaptHealth Corp. Market vs Earnings Trajectory

AHCO ยท NASDAQ

Loading price and EPS data...

AdaptHealth Corp.

AdaptHealth Corp. Fair Value Envelope

AHCO ยท NASDAQ

Our analysis suggests that AHCO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $9.72, this represents a potential HIDDEN relative to our calculated worth for AdaptHealth Corp..

Intrinsic Value
Current Price: $9.72
3Y-200.0%
5Y-58.0%
10Y+330.0%
3Y+9.0%
5Y+207.0%
10Y+1761.0%
3Y-202.0%
5Y-56.0%
10Y+1766.0%
3Y+61.0%
5Y+208.0%
10Y+1910.0%
3Y-1350.0%
5Y+41.0%
10Y+699.0%
3Y-17.0%
5Y+138.0%
10Y+1389583.0%
AdaptHealth Corp.

AdaptHealth Corp. Profit Bridge

AHCO ยท NASDAQ
Revenue3.24B
Cost of Goods Sold (2.68B)
Gross Profit568.56M
Operating Expenses (382.29M)
Operating Income186.27M
Interest Expense (105.75M)
Other Income/Expense-201.42M
Pretax Income-15.15M
Income Tax (50.88M)
Net Income-70.79M
Net Income
-70.79M

Profitability Analysis

Gross Margin

17.5%

Thin margins leave little room for error. Cost management and pricing strategy are critical.

Operating Margin

5.7%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

-2.2%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Non-operating losses: Core business is profitable but other expenses (interest, taxes, one-time items) are driving net losses. Review capital structure and non-operating items.

17.52%
Gross Profit Margin
-16%
3Y+25.0%
5Y+17.0%
10Y+95.0%
5.74%
Operating Profit Margin
-29%
3Y-10.0%
5Y-15.0%
10Y+331.0%
-2.18%
Net Profit Margin
-179%
3Y-193.0%
5Y-86.0%
10Y-
-4.66%
Return on Equity
-181%
3Y-245.0%
5Y-90.0%
10Y-
-1.64%
Return on Assets
-181%
3Y-223.0%
5Y-82.0%
10Y-
5.07%
Return on Invested Capital
10%
3Y+72.0%
5Y+7.0%
10Y-
AHCO

AdaptHealth Corp. Cash Conversion Engine

AHCO ยท NASDAQ
Net Income-66.04M
Depreciation & Amortization381.93M
Stock-Based Compensation21.88M
Change in Working Capital66.58M
Others150.26M
Capital Expenditures-382.39M
Free Cash Flow219.38M

Cash Flow Quality Analysis

FCF Conversion Rate

-332.2%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

63.5%

Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.

FCF Growth Trend

-7.0%

Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.

Working Capital Impact

+$66.58M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Capital-intensive growth: Heavy reinvestment limits current cash available but may drive future returns. Assess whether CapEx supports compelling growth opportunities with adequate ROI.

ahco

AdaptHealth Corp. Funding & Solvency Profile

AHCO ยท NASDAQ
Cash & Cash Equivalents47.96M
Net Receivables391.97M
Inventory159.27M
Other Current Assets88.28M
Total Current Assets687 M
Property, Plant & Equipment795.08M
Goodwill & Intangible Assets2.65B
Long-Term Investments0.00
Other Non-Current Assets18.80M
Total Non-Current Assets814 M
Total Assets
4.42B

Financial Health Analysis

Current Ratio

0.92x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.92x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-55811000

Negative working capital indicates short-term liabilities exceed short-term assetsโ€”potential liquidity stress.

Asset Composition

16% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

ahco

AdaptHealth Corp. Street Expectations Map

AHCO ยท NASDAQ

Wall Street analysts project that AHCO stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 14.40, with estimates ranging from a low of 11.00 to a high of 18.00.

Lowest Target
11.00
13.17%
Consensus Target
14.40
48.15%
Highest Target
18.00
85.19%

The consensus 1-year price target stands at 14.40, with estimates ranging from a low of 11.00 to a high of 18.00.

Analyst Consensus Analysis

Upside Potential

+48.1%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

48.6% spread

Mixed analyst views. Wide target range suggests differing opinions on key value drivers, growth prospects, or risk factors.

Analyst Conviction

Moderate

Neutral sentiment. Fair value pricing with moderate agreement suggests wait-and-see approach or catalyst-driven opportunity.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

ahco

AdaptHealth Corp. Insider Positioning

AHCO ยท NASDAQ

During the last 12 months, insiders have purchased $48.82M and sold $127K worth of AHCO shares, resulting in $48.69M of net buying activity.

3 Months

Bought

5.0M

48.70M

Sold

0

0.00

Net Activity

+48.7M

+$48.70M

3-6 Months

Bought

13.0K

116.23K

Sold

0

0.00

Net Activity

+116K

+$116K

6-9 Months

Bought

0

0.00

Sold

5.0K

47.15K

Net Activity

-47K

-$47K

9-12 Months

Bought

0

0.00

Sold

8.2K

79.79K

Net Activity

-80K

-$80K

Top Buyers

1
CRMJ

Cashin Richard M Jr

10 Percent Owner

2.5M sharesโ€ข5 transactions

$24.35M

2
OVGL

Oep Vii Gp, L.L.C.

10 Percent Owner

2.5M sharesโ€ข5 transactions

$24.35M

3
WDB

Wolf Dale B

Director

8.0K sharesโ€ข1 transactions

$72K

4
RRWI

Rew Richard W. Ii

Officer: Clo And General Counsel

5.0K sharesโ€ข1 transactions

$45K

Top Sellers

1
WDSI

Williams David Solomon Iii

Director

13.2K sharesโ€ข2 transactions

$127K

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $48.69M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

384.59:1

Exceptional buy/sell ratio. Buying dramatically outweighs sellingโ€”one of the strongest possible insider signals.

Recent Trend (3 Months)

$48.70M

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

4 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.

0.00%
Dividend Yield
3Y-
5Y-
10Y-
ย 

ahco Dividend History

AHCO
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%